OOIR: Observatory of International Research

Papers

(The TQCC of Alzheimer Disease & Associated Disorders is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
The Measurement of Everyday Cognition (ECog)	19
Mild Alzheimer Disease, Financial Capacity, and the Role of Depression	18
Effects of Noninvasive Brain Stimulation (NIBS) on Cognitive Impairment in Mild Cognitive Impairment and Alzheimer Disease	17
Sociodemographic and Clinical Characteristics of 1350 Patients With Young Onset Dementia	14
Racial/Ethnic Disparities in Young Adulthood and Midlife Cardiovascular Risk Factors and Late-life Cognitive Domains	13
Patient and Relative Experiences and Decision-making About Genetic Testing and Counseling for Familial ALS and FTD	13
Predictors of Willingness to Enroll in Hypothetical Alzheimer Disease Biomarker Studies that Disclose Personal Results	12
Bone Mineral Density Measurements and Association With Brain Structure and Cognitive Function	12
Physical Performance and Cognition in a Diverse Cohort	12
Clinical Care and Unmet Needs of Individuals With Dementia With Lewy Bodies and Caregivers	10
Prevalence of Mild Cognitive Impairment in the Lothian Birth Cohort 1936	9
Cognitive Behavioral Therapy for Mood and Insomnia in Persons With Dementia	9
Assessment of Functional Near-infrared Spectroscopy by Comparing Prefrontal Cortex Activity	8
Intravesical BCG and Incidence of Alzheimer Disease in Patients With Bladder Cancer	8
Genetic Variants and Haplotypes of TOMM40, APOE, and APOC1 are Related to the Age of Onset of Late-onset Alzheimer Disease in a Colombian Population	7
Outcome Measures for Dementia With Lewy Body Clinical Trials	7
The Association Between Patterns of Social Engagement and Conversion From Mild Cognitive Impairment to Dementia	7
Association Between GlycA and Cognitive Function	6
Early Impairment in the Ventral Visual Pathway Can Predict Conversion to Dementia in Patients With Amyloid-negative Amnestic Mild Cognitive Impairment	6
Phase 1 Single Ascending and Multiple Ascending Dose Studies of Phosphodiesterase-9 Inhibitor E2027	6
Effects of Depression on Changes in Cognitive Function in Older Adults	6
Long-term Neuropsychiatric Complications and 18F-FDG-PET Hypometabolism in the Brain From Prolonged Infection of COVID-19	6
Right Temporal Lobe Variant of Frontotemporal Dementia	6
Meta-analysis of the Connection Between Alzheimer Disease and Telomeres	6
Functional Decline and Body Composition Change in Older Adults With Alzheimer Disease	6

Beliefs, Understanding, and Barriers Related to Dementia Research Participation Among Older African Americans	6
Genetic Variants Associated With Alzheimer Disease in the 22 Arab Countries	6
The Impact of Episodes of Lucidity on People Living With Dementia and Their Caregivers	6
Novel PSEN1 and PSEN2 Mutations Identified in Sporadic Early-onset Alzheimer Disease and Posterior Cortical Atrophy	5
Engaging Diverse Older Adults With Cognitive Impairment and Caregivers in Advance Care Planning	5
Cerebral Amyloid Angiopathy-related Inflammation Presenting With a Cystic Lesion in Young-onset Alzheimer Disease	5
Obesity and Oxidative Stress in Older Adults At Risk for Dementia	5
Polymorphism in the MAGI2 Gene Modifies the Effect of Amyloid β on Neurodegeneration	5
Association Between Adherence to the MIND Diet and Cognitive Performance is Affected by Income	5
Perceptions of Research Burden and Retention Among Participants in ADRC Cohorts	5
Impact of Disturbed Rest-activity Rhythms on Activities of Daily Living in Moderate and Severe Dementia Patients	5
Limited Longitudinal Change in Self-reported Spatial Navigation Ability in Preclinical Alzheimer Disease	4
Role of Apolipoprotein E in the Clinical Profile of Atypical Parkinsonian Syndromes	4
Evaluation of the Clinical Features Accompanied by the Gene Mutations	4
Does a Cancer Diagnosis in Mid-to-Later Life Modify Racial Disparities in Memory Aging?	4
Subtle Changes in Medication-taking Are Associated With Incident Mild Cognitive Impairment	4
Carotid Intima-Media Thickness (cIMT) and Cognitive Performance	4
The Relationship Between Decision-making Capacity and the Domains of Awareness in Alzheimer Disease	4
Evolving Causes of Rapidly Progressive Dementia	4
Musical Bridges to Memory	4
Economic Burden of Chronic Comorbidities Among Community-Dwelling Older Adults With Dementia	4
Familiarity in Mild Cognitive Impairment as a Function of Patients’ Clinical Outcome 4 Years Later	4
Changes in Polypharmacy and Psychotropic Medication Use After Diagnosis of Major Neurocognitive Disorders	4
Temporal Speech Parameters Indicate Early Cognitive Decline in Elderly Patients With Type 2 Diabetes Mellitus	4
Healthy Lifestyle Behaviors and Viewpoints Among Members of an Alzheimer Prevention Registry	4
Gray Matter Volume as Evidence for Cognitive Reserve in Bilinguals With Mild Cognitive Impairment	3
Proteomic Analysis Reveals Potential Exosomal Biomarkers in Patients With Sporadic Alzheimer Disease	3
Decreased Expression of Cerebral Dopamine Neurotrophic Factor in Platelets of Probable Alzheimer Patients	3
Brain 18F-Florbetapir PET/CT Findings in an Early-onset Alzheimer Disease Patient Carrying Presenilin-1 G378E Mutation	3
Predictors of Cognitive Change in Parkinson Disease	3
Pure Prosodic Type of Primary Progressive Apraxia of Speech Mimicking Nonfluent Aphasia and Later Progressing to Corticobasal Syndrome	3
Postsecondary Education and Late-life Cognitive Outcomes Among Black and White Participants in the Project Talent Aging Study	3
Novel Presenilin-1 Mutation (Ala275Ser) Associated With Clinical Features of Dementia With Lewy Bodies	3
Family Caregiver Comorbidities in Lewy Body Dementia Versus Alzheimer Disease and Associated Disorders	3
Examining the Role of Aging Perceptions in Subjective Cognitive Decline	3
Physical Exercise as a Nonpharmacological Intervention for the Treatment of Neuropsychiatric Symptoms in Persons With Dementia	3
Research Priorities of Individuals and Caregivers With Lewy Body Dementia	3
Psychological Impact of Predictive Genetic Testing for Inherited Alzheimer Disease and Frontotemporal Dementia	3
Alzheimer’s Disease Neuropathologic Change and Vitamin Supplement Use Decades Earlier	3
β-Amyloid Orchestrates Factor XII and Platelet Activation Leading to Endothelial Dysfunction and Abnormal Fibrinolysis in Alzheimer Disease	3
Effect of Neurotoxin Exposure on Blood Biomarkers of Neurodegeneration and Alzheimer Disease	3
Apolipoprotein E4 Moderates the Association Between Vascular Risk Factors and Brain Pathology	3
Psychosocial and Behavioral Outcomes for Persons With Cognitive Impairment and Caregivers Following Amyloid-β PET Scan Disclosure	3
Impaired Color Discrimination in Alzheimer Disease Dementia	3
CSF α-Synuclein and Tau as Biomarkers for Dementia With Lewy Bodies	3